title: [Bibrocathol eye ointment is efficacious in blepharitis. Results from a randomized, double-blind, controlled clinical trial].
abstract: Bibrocathol (Noviform) 5% ointment is a frequently used therapy for blepharitis. The study included 197 patients who were randomized to be treated over 2 weeks with bibrocathol or an ointment vehicle, respectively. Slit lamp examinations were performed on day 1 (baseline) and day 14 (end of study) to assess lid edema, lid erythema, debris, and pouting of Meibomian glands; patients rated their subjective complaints. Bibrocathol was superior to the control treatment in improving the sum score of the 5 scales (by 7.0 vs 4.7 points, p<0.001), especially in patients with primarily severe symptoms (by 8.3 vs 4.8, p<0.0001). Antiseptic therapy with bibrocathol eye ointment 3 times daily over 2 weeks was found to be efficacious in the treatment of acute forms of blepharitis which do not require antibiotic therapy. Bibrocathol treatment is well tolerated and safe.
authors.affiliation: Universitätsaugenklinik Magdeburg, Leipziger Strasse 44, Haus 60b, 39120 Magdeburg, Germany. augenklinik@uni-magdeburg.de
authors.forename: W
authors.initials: W
authors.lastname: Behrens-Baumann
authors.forename: C
authors.initials: C
authors.lastname: Niederdellmann
authors.forename: A
authors.initials: A
authors.lastname: Jehkul
authors.forename: R
authors.initials: R
authors.lastname: Kohnen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001762:Blepharitis / Q000188:drug therapy*; D002396:Catechols / Q000008:administration & dosage* / Q000009:adverse effects; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D016896:Treatment Outcome
chemical_list: D002396:Catechols; D009824:Ointments; C006748:bibrocathol